Synthesis of Gold-Capped Mesoporous Silica Nanocarriers to Enhance Chemotherapeutic Efficacy Through Green Light Photodynamic Therapy

Year 2025, Volume: 14 Issue: 3, 257 - 270, 31.12.2025

Gunel Abbasova Ayşe Işık Burcu Güleryüz Erkovan

https://doi.org/10.54187/jnrs.1706026

Abstract

Porous silica nanocarriers have gained prominence for the delivery of various anticancer drugs due to their excellent surface functionalization capabilities and potential to mitigate undesirable side effects. In this study, gold nanoparticles were synthesized through a seed-mediated growth method (with diameters ranging from 7 to 10 nm) and conjugated onto mesoporous silica nanocarriers via amine-gold interactions. The large pore channels of nanocarriers were efficiently loaded with the anticancer drug doxorubicin. Physicochemical characterization was comprehensively performed using dynamic light scattering, scanning transmission electron microscopy, Fourier transform infrared spectroscopy, and an absorption spectrophotometer. The mesoporous silica nanocarriers demonstrated a rod-shaped morphology, approximately 150 nm in length and 100 nm in width. Leveraging the strong optical absorption of gold nanoparticles at 530 nm, the synergistic effect of green-light-mediated photodynamic therapy and chemotherapy was investigated on prostate cancer cells. The co-therapies successfully reduced cell viability by 54% at a concentration of 400 µg/mL nanocarriers after 10 minutes of green light exposure (540 nm, 100 mW/cm², continuous wave), demonstrating the potential of this minimally invasive treatment strategy. Our findings suggest that gold-decorated porous silica nanocarriers can effectively act as a multifunctional platform by merging chemotherapy and photodynamic therapy to enhance cancer treatment outcomes.

Keywords

Mesoporous silica nanoparticles , gold nanoparticles , chemotherapy , photodynamic therapy , prostate cancer

Ethical Statement

No approval from the Board of Ethics is required.

Supporting Institution

This study was supported by Haliç University.

Thanks

The authors thank Assist. Prof. Dr Mustafa K. Ruhi for his valuable supports from the Biophotonics Laboratory (Boğazici University).

References

• B. Wang, S. Hu, Y. Teng, J. Chen, H. Wang, Y. Xu, K. Wang, J. Xu, Y. Cheng, X. Gao, Current advance of nanotechnology in diagnosis and treatment for malignant tumors, Signal Transduction and Targeted Therapy 9 (1) (2024) 200.
• V. K. Chaturvedi, A. Singh, V. K. Singh, M. P. Singh, Cancer nanotechnology: A new revolution for cancer diagnosis and therapy, Current Drug Metabolism 20 (6) (2019) 416–429.
• K. B. Seljak, P. Kocbek, M. Gašperlin, Mesoporous silica nanoparticles as delivery carriers: An overview of drug loading techniques, Journal of Drug Delivery Science and Technology 59 (2020) 101906.
• T. Li, S. Shi, S. Goel, X. Shen, X. Xie, Z. Chen, H. Zhang, S. Li, X. Qin, H. Yang, C. Wu, Y. Liu, Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer, Acta Biomaterialia 89 (2019) 1–13.
• M. Gisbert-Garzarán, M. Vallet-Regí, Influence of the surface functionalization on the fate and performance of mesoporous silica nanoparticles, Nanomaterials 10 (5) (2020) 916.
• A. Watermann, J. Brieger, Mesoporous silica nanoparticles as drug delivery vehicles in cancer, Nanomaterials 7 (7) (2017) 189.
• S. Mohanan, C.I. Sathish, K. Ramadass, M. Liang, A. Vinu, Design and synthesis of cabazitaxel loaded core-shell mesoporous silica nanoparticles with different morphologies for prostate cancer therapy, Small 20 (39) (2024) 2303269.
• Y. Zhao, Y. Wang, F. Ran, Y. Cui, C. Liu, Q. Zhao, Y. Gao, D. Wang, S. Wang, A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics, Scientific Reports 7 (1) (2017) 4131.
• L. Sutrisno, K. Ariga, Pore-engineered nanoarchitectonics for cancer therapy, NPG Asia Materials 15 (2023) 21.
• C. M. Liu, G. B. Chen, H. H. Chen, J. B. Zhang, H. Z. Li, M. X. Sheng, W. B. Weng, S. M. Guo, Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment, Colloids and Surfaces B: Biointerfaces 175 (2019) 477–486.
• M. M. Gottesman, Mechanisms of cancer drug resistance, Annual Review of Medicine 53 (1) (2002) 615–627.
• K. Hu, D. Zhang, W. Ma, Y. Gu, J. Zhao, X. Mu, Polydopamine-based nanoparticles for synergistic chemotherapy of prostate cancer, International Journal of Nanomedicine 19 (2024) 6717–6730.
• M. Osuchowski, D. Bartusik-Aebisher, F. Osuchowski, D. Aebisher, Photodynamic therapy for prostate cancer – A narrative review, Photodiagnosis and Photodynamic Therapy 33 (2021) 102158.
• S. Chhatre, A. Vachani, R.R. Allison, R. Jayadevappa, Survival outcomes with photodynamic therapy, chemotherapy and radiation in patients with stage III or stage IV non-small cell lung cancer, Cancers 13 (4) (2021) 803.
• B. Güleryüz, U. Ünal, M. Gülsoy, Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: An in vitro study, Photodiagnosis and Photodynamic Therapy 36 (2021) 102616.
• M. Broadbent, S. J. Chadwick, M. Brust, M. Volk, Gold nanoparticles for photothermal and photodynamic therapy, ACS Omega 9 (44) (2024) 44846–44859.
• R. Fenger, E. Fertitta, H. Kirmse, A. F. Thünemann, K. Rademann, Size dependent catalysis with CTAB-stabilized gold nanoparticles, Physical Chemistry Chemical Physics 14 (26) (2012) 9343–9349.
• Y. S. Lin, C. L. Haynes, Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity, Journal of the American Chemical Society 132 (13) (2010) 4834–4842.
• P. Eskandari, B. Bigdeli, M. P. Daryasari, H. Baharifar, B. Bazri, M. Shourian, A. Amani, A. Sadighi, B. Goliaei, M. Khoobi, A.A. Saboury, Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery, Journal of Drug Targeting 27 (10) (2019) 1084–1093.
• T. N. T. Nguyen, N. T. T. Le, N. H. Nguyen, B. T. K. Ly, T. D. Nguyen, D. H. Nguyen, Aminated hollow mesoporous silica nanoparticles as an enhanced loading and sustained releasing carrier for doxorubicin delivery, Microporous and Mesoporous Materials 309 (2020) 110543.
• P. A. Jenkins, J. D. Carroll, How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies, Photomedicine and Laser Surgery 29 (12) (2011) 785–787.
• T. Entradas, S. Waldron, M. Volk, The detection sensitivity of commonly used singlet oxygen probes in aqueous environments, Journal of Photochemistry and Photobiology B: Biology 204 (2020) 111787.
• I. Petreanu, V. C., Niculescu, S., Enache, C., Iacob, M., Teodorescu, Structural characterization of silica and amino-silica nanoparticles by Fourier transform infrared (FTIR) and Raman spectroscopy, Analytical Letters 56 (2) (2023) 390–403.
• C. Yao, L. Zhang, J. Wang, Y. He, J. Xin, S. Wang, H. Xu, Z. Zhang, Gold nanoparticle mediated phototherapy for cancer, Journal of Nanomaterials 2016 (1) (2016) 5497136.
• S. Park, R. R. Ang, S. P. Duffy, J. Bazov, K. N. Chi, P. C. Black, H. Ma, Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells, PLoS One 9 (1) (2014) e85264.
• K. W. Dunn, M. M. Kamocka, J. H. McDonald, A practical guide to evaluating colocalization in biological microscopy, American Journal of Physiology - Cell Physiology 300 (4) (2011) C723–C742.
• Y. Malinovskaya, P. Melnikov, V. Baklaushev, A. Gabashvili, N. Osipova, S. Mantrov, Y. Ermolenko, O. Maksimenko, M. Gorshkova, V. Balabanyan, J. Kreuter, S. Gelperina, Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells, International Journal of Pharmaceutics 524 (1-2) (2017) 77–90.
• A. C. Anselmo, S. Mitragotri, An overview of clinical and commercial impact of drug delivery systems, Journal of Controlled Release 190 (2014) 15–28.
• H. Serrage, V. Heiskanen, W. M. Palin, P. R. Cooper, M. R. Milward, M. Hadis, M. R. Hamblin, Under the spotlight: Mechanisms of photobiomodulation concentrating on blue and green light, Photochemical and Photobiological Sciences 18 (8) (2019) 1877–1909.